Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are fatal diseases; however, their pathogenesis still remains to be elucidated. We have recently screened novel pathogenic molecules and have performed drug discovery targeting those molecules. Pulmonary...

Full description

Bibliographic Details
Main Authors: Kimio Satoh, Nobuhiro Kikuchi, Taijyu Satoh, Ryo Kurosawa, Shinichiro Sunamura, Mohammad Abdul Hai Siddique, Junichi Omura, Nobuhiro Yaoita, Hiroaki Shimokawa
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:International Journal of Molecular Sciences
Subjects:
pathogenesis
pulmonary hypertension
biomarker
drug discovery
Online Access:https://www.mdpi.com/1422-0067/19/12/4081

Internet

https://www.mdpi.com/1422-0067/19/12/4081

Similar Items